JPWO2023099494A5 - - Google Patents
Info
- Publication number
- JPWO2023099494A5 JPWO2023099494A5 JP2024532266A JP2024532266A JPWO2023099494A5 JP WO2023099494 A5 JPWO2023099494 A5 JP WO2023099494A5 JP 2024532266 A JP2024532266 A JP 2024532266A JP 2024532266 A JP2024532266 A JP 2024532266A JP WO2023099494 A5 JPWO2023099494 A5 JP WO2023099494A5
- Authority
- JP
- Japan
- Prior art keywords
- chemically modified
- modified oligonucleotide
- bonds
- nucleotide
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21211372.4 | 2021-11-30 | ||
| EP21211372 | 2021-11-30 | ||
| PCT/EP2022/083711 WO2023099494A1 (en) | 2021-11-30 | 2022-11-29 | Antisense oligonucleotides (aso) for efficient and precise rna editing with endogenous adenosine deaminase acting on rna (adar) |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024544067A JP2024544067A (ja) | 2024-11-27 |
| JP2024544067A5 JP2024544067A5 (https=) | 2025-12-11 |
| JPWO2023099494A5 true JPWO2023099494A5 (https=) | 2025-12-11 |
Family
ID=78820190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532266A Pending JP2024544067A (ja) | 2021-11-30 | 2022-11-29 | Ｒｎａに作用する内因性アデノシンデアミナーゼ（ａｄａｒ）による効率的および正確なｒｎａ編集のためのアンチセンスオリゴヌクレオチド（ａｓｏ） |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230235329A1 (https=) |
| EP (1) | EP4441216A1 (https=) |
| JP (1) | JP2024544067A (https=) |
| KR (1) | KR20240111752A (https=) |
| CN (1) | CN118355119A (https=) |
| AU (1) | AU2022399905A1 (https=) |
| CA (1) | CA3238033A1 (https=) |
| IL (1) | IL312762A (https=) |
| WO (1) | WO2023099494A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024114908A1 (en) * | 2022-11-30 | 2024-06-06 | Eberhard Karls Universität Tübingen | Chemically modified antisense oligonucleotides (asos) and compositions comprising the same for rna editing |
| AU2024325709A1 (en) * | 2023-08-15 | 2026-01-29 | Airna Corporation | Chemically modified antisense oligonucleotides (asos) and compositions for rna editing |
| WO2025073902A1 (en) * | 2023-10-06 | 2025-04-10 | Eberhard Karls Universität Tübingen | Chemical and sequence optimisation of antisense oligonucleotides for adar-mediated rna editing |
| WO2025172372A1 (en) | 2024-02-12 | 2025-08-21 | Airna Corporation | Conjugate for targeted delivery of an antisense oligonucleotide |
| WO2025242018A1 (zh) * | 2024-05-20 | 2025-11-27 | 时夕(广州)生物科技有限公司 | 一种经修饰的向导agRNA |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10941402B2 (en) | 2016-09-01 | 2021-03-09 | Proqr Therapeutics Ii B.V. | Chemically modified single-stranded RNA-editing oligonucleotides |
| WO2020001793A1 (en) | 2018-06-29 | 2020-01-02 | Eberhard-Karls-Universität Tübingen | Artificial nucleic acids for rna editing |
| CA3158528A1 (en) * | 2019-12-23 | 2021-07-01 | Jim SWILDENS | Antisense oligonucleotides for nucleotide deamination in the treatment of stargardt disease |
-
2022
- 2022-11-29 WO PCT/EP2022/083711 patent/WO2023099494A1/en not_active Ceased
- 2022-11-29 EP EP22823405.0A patent/EP4441216A1/en active Pending
- 2022-11-29 CN CN202280079432.9A patent/CN118355119A/zh active Pending
- 2022-11-29 AU AU2022399905A patent/AU2022399905A1/en active Pending
- 2022-11-29 CA CA3238033A patent/CA3238033A1/en active Pending
- 2022-11-29 KR KR1020247016720A patent/KR20240111752A/ko active Pending
- 2022-11-29 JP JP2024532266A patent/JP2024544067A/ja active Pending
- 2022-11-29 IL IL312762A patent/IL312762A/en unknown
- 2022-11-30 US US18/071,999 patent/US20230235329A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5696253A (en) | Polynucleoside chain with 3'→5' guanidyl linkages | |
| JP2024038326A5 (https=) | ||
| JP2025165976A5 (https=) | ||
| US10358459B2 (en) | 2′-arabino-fluorooligonucleotide N3′˜P5′ phosphoramidates: their synthesis and use | |
| JP2024038327A5 (https=) | ||
| JP2024088642A5 (https=) | ||
| DE60038495T2 (de) | Oligonukleotid n3'-p5' thiophosphoramidate: ihre synthese und verwendung | |
| JP2021512629A5 (https=) | ||
| DE69635744T2 (de) | Modifizierte Nukleinsäuresonden | |
| JP6571663B2 (ja) | 逆方向アプローチを使用した長いｒｎａの非常に効果的な合成 | |
| US11584773B2 (en) | Phosphorous protecting groups and methods of preparation and use thereof | |
| JPWO2019157531A5 (https=) | ||
| CN113994000A (zh) | 包括胞苷类似物的反义rna编辑寡核苷酸 | |
| JPWO2019237069A5 (https=) | ||
| PT845476E (pt) | Oligonucleotidos cataliticos sinteticos | |
| CZ129197A3 (en) | Nucleosides with modified sugar portion of a molecule and their use for preparing oligonucleotides | |
| JP2021515784A5 (https=) | ||
| JPWO2023099494A5 (https=) | ||
| Lum et al. | Human intestinal es nucleoside transporter: molecular characterization and nucleoside inhibitory profiles | |
| JPWO2019140452A5 (https=) | ||
| Naval et al. | 2-Amino-α-2′-deoxyadenosine increased duplex stability of methoxyethylphosphoramidate α-Oligodeoxynucleotides with RNA target | |
| EP0931090B1 (en) | Improved chimeric oligonucleotide vectors | |
| JPWO2023098908A5 (https=) | ||
| JPWO2023091644A5 (https=) | ||
| Holz et al. | Higher Binding Affinity of Duplex Oligodeoxynucleotides Containing 1, 2-Dideoxy-D-Ribose to The N6-Adenine DNA Methyltransferase M· TAQ I Supports a Base Flipping Mechanism |